Skip to main content

Table 1 Demographic characteristics

From: Correlation analysis of epicardial adipose tissue thickness, C-reactive protein, interleukin-6, visfatin, juxtaposed with another zinc finger protein 1, and type 2 diabetic macroangiopathy

  Complications Group
(n = 82)
Diabetes Group
(n = 85)
Healthy Control Group(n = 90) χ2/t P value
Gender (male/female) 43/39 45/40 47/43 0.009 0.996
Age (years) 55.4 ± 5.2 55.9 ± 6.2 56.1 ± 6.2 0.355 0.702
WHR 1.03 ± 0.03a,b 0.95 ± 0.05 0.91 ± 0.06 133.612 <0.001
BMI (kg/m2) 25.02 ± 2.28 24.79 ± 2.12 24.02 ± 2.39 0.331 0.719
Duration of diabetes (years) 4.03 ± 0.38 3.97 ± 0.41 0.981 0.328
Medications for diabetes and dyslipidemia     1.428 0.629
 Insulin 33 (37.80) 33 (38.82)    
 Dimethyldiguanide 29 (35.37) 27 (31.76)    
 Alpha-glucosidase inhibitor 15 (18.29) 28 (32.94)    
 Statins 20 (24.39) 28 (32.94)    
  1. acompare with Diabetes Group (P<0.05); bcompare with Healthy Control Group (P<0.05); WHR waist hip ratio, BMI body mass index
\